Zahonero, C., Aguilera, P., Ramírez-Castillejo, C., Pajares, M., Bolos, V., Cantero, D., . . . Sepúlveda, J. M. (2015). Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.
Citación estilo ChicagoZahonero, Cristina, et al. Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma. 2015.
Cita MLAZahonero, Cristina, et al. Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma. 2015.
Precaución: Estas citas no son 100% exactas.